Facebook Twitter LinkedIn Email Share

Drugmakers May Turn to Bankruptcy to Lessen Opioid Liability

The U.S. opioid crisis and the avalanche of lawsuits it has produced may lead numerous pharmaceutical companies to seek bankruptcy relief, perhaps rivaling the asbestos bankruptcies of the late 1990s and early 2000s.

New legal actions are being filed against pharmaceutical manufacturers...


We hope you enjoyed your free content!

To continue, please become a TMA member.
  • Access the Journal of Corporate Renewal and other content in the Learning Link.
  • Become part of a global organization of turnaround and restructuring professionals with 53 Chapters and more than 400 events each year.
  • Build your personal brand and professional network with opportunities to connect, speak, lead, and win awards.

Join Today

TMA Print Logo